Emergence of homogeneously methicillin-resistant Staphylococcus aureus

Area of Science:

• Microbiology
• Infectious Diseases
• Antimicrobial Resistance

Background:

• Methicillin-resistant Staphylococcus aureus (MRSA) is a significant pathogen.
• Understanding MRSA resistance patterns is crucial for effective treatment.
• Clinical isolates from 1986-1990 provide insight into historical resistance trends.

Purpose of the Study:

• To analyze antibiotic susceptibility of MRSA clinical isolates.
• To differentiate resistance patterns between homogeneous and heterogeneous MRSA.
• To identify potential markers for homogeneous MRSA strains.

Main Methods:

• Analysis of 47 MRSA clinical isolates collected between 1986 and 1990.
• Determination of antibiotic susceptibility to gentamicin, clindamycin, trimethoprim-sulfamethoxazole, methicillin, and imipenem.
• Classification of strains into homogeneous and heterogeneous methicillin resistance categories.

Main Results:

• Homogeneous MRSA strains showed higher minimum inhibitory concentrations (MICs) for gentamicin, clindamycin, trimethoprim-sulfamethoxazole, methicillin, and imipenem compared to heterogeneous strains.
• Most strains remained susceptible to vancomycin and trimethoprim-sulfamethoxazole.
• Ciprofloxacin resistance emerged post-1987, comprising 40% of later isolates.
• A strong correlation was observed between methicillin resistance level and imipenem MIC.

Conclusions:

• Homogeneous MRSA strains exhibit distinct antibiotic resistance profiles.
• Imipenem susceptibility may serve as a reliable marker for identifying homogeneous MRSA.
• Monitoring imipenem susceptibility can help track the prevalence of homogeneous MRSA strains.